| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total operating revenue | 345,253 | 355,788 | 373,225 | 362,124 |
| Medical expense | 369,789 | 351,350 | 372,043 | 401,920 |
| Premium deficiency reserve | -23,736 | -5,967 | -6,962 | 18,168 |
| Corporate, general and administrative expense | 22,139 | 23,295 | 24,999 | 27,219 |
| Sales and marketing expense | 251 | 151 | 181 | 134 |
| Depreciation and amortization | 21,033 | 21,083 | 21,052 | 21,673 |
| Total operating expense | 389,476 | 389,912 | 411,313 | 469,114 |
| Operating loss | -44,223 | -34,124 | -38,088 | -106,990 |
| Interest expense, net | -20,527 | -10,145 | -8,725 | -5,647 |
| Mark-to-market of stock warrants | 2,540 | -2,002 | -3,322 | -5,737 |
| Other | -2,160 | 583 | 318 | 445 |
| Total other income (expense) | -25,227 | -7,560 | -5,085 | 535 |
| Loss before income taxes | -69,450 | -41,684 | -43,173 | -106,455 |
| Income tax benefit (provision) | 11 | 1,981 | 1,073 | -3,605 |
| Net loss | -69,461 | -43,665 | -44,246 | -102,850 |
| Less net loss attributable to redeemable non-controlling interest | -37,874 | -23,303 | -23,766 | -56,338 |
| Net loss attributable to controlling interest | -31,587 | -20,362 | -20,480 | -46,512 |
| Basic (in dollars per share) | -9.67 | -6.23 | -6.28 | -0.29 |
| Basic (in shares) | 3,268,000 | 3,267,000 | 3,260,000 | 161,890,000 |
| Diluted (in dollars per share) | -9.67 | -6.23 | -6.28 | -0.31 |
| Diluted (in shares) | 3,268,000 | 3,267,000 | 3,260,000 | 164,701,000 |
P3 Health Partners Inc. (PIII)
P3 Health Partners Inc. (PIII)